Statement of Changes in Beneficial Ownership (4)

Date : 10/04/2019 @ 8:15PM
Source : Edgar (US Regulatory)
Stock : Diplomat Pharmacy Inc (DPLO)
Quote : 4.0  0.0 (0.00%) @ 12:00AM
Diplomat Pharmacy share price Chart

Statement of Changes in Beneficial Ownership (4)

FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Hagerman Philip R
2. Issuer Name and Ticker or Trading Symbol

Diplomat Pharmacy, Inc. [ DPLO ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

4100 S. SAGINAW STREET
3. Date of Earliest Transaction (MM/DD/YYYY)

10/2/2019
(Street)

FLINT, MI 48507
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  10/2/2019    S(1)    2610 (1) D $4.8002 (2) 35871  D   
Common Stock                 1280099  I  Philip R. Hagerman Revocable Trust (3)
Common Stock                 3391609  I  2007 Hagerman Family GST (4)
Common Stock                 3600091  I  The JH GST Trust (3)
Common Stock                 1475876  I  2013 Irrev. Exempt Trust for Daughter (4)
Common Stock                 1475876  I  2013 Irrev. Exempt Trust for Son (4)
Common Stock                 1075293  I  2013 Irrev. Exempt Trust for Daughter (3)
Common Stock                 1311292  I  2013 Irrev. Exempt Trust for Daughter (3)
Common Stock                 313337  I  2014 Irrev. Exempt Trust for Son (4)
Common Stock                 313337  I  2014 Irrev. Exempt Trust for Daughter (4)
Common Stock                 313337  I  2014 Irrev. Exempt Trust for Daughter (3)
Common Stock                 313337  I  2014 Irrev. Exempt Trust for Daughter (3)
Common Stock                 367528  I  Jocelyn Hagerman Living Trust (4)
Common Stock                 263500  I  JH Marital Trust (3)
Common Stock                 272000  I  PH Marital Trust (4)
Common Stock                 394910  I  Irrevocable Trust for Son 
Common Stock                 394910  I  Irrevocable Trust for Daughter 
Common Stock                 367256  I  Irrevocable Non-Exempt Trust for Son 
Common Stock                 367256  I  Irrevocable Non-Exempt Trust for Daughter 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  The sales reported in this Form 4 represent shares sold automatically to cover the tax liability incurred incident to the vesting of previously granted restricted stock.
(2)  The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $4.72 to $4.85. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
(3)  These shares are indirectly owned by Mr. Hagerman as the trustee of the Philip R. Hagerman Revocable Trust, The JH GST Trust, the 2013 Irrevocable Exempt Trusts and 2014 Irrevocable Exempt Trusts for two daughters, and the JH Marital Trust.
(4)  Jocelyn Hagerman is Mr. Hagerman's wife. These shares are indirectly owned by her as a trustee of the 2007 Hagerman Family GST Trust, the 2013 Irrevocable Exempt Trusts and 2014 Irrevocable Exempt Trusts for a son and daughter, the Jocelyn Hagerman Living Trust, and the PH Marital Trust.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Hagerman Philip R
4100 S. SAGINAW STREET
FLINT, MI 48507
X X


Signatures
/s/ Christina Flint, by Power of Attorney 10/4/2019
**Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Diplomat Pharmacy (NYSE:DPLO)
Historical Stock Chart

1 Year : From Feb 2019 to Feb 2020

Click Here for more Diplomat Pharmacy Charts.

Diplomat Pharmacy (NYSE:DPLO)
Intraday Stock Chart

Today : Tuesday 25 February 2020

Click Here for more Diplomat Pharmacy Charts.

Latest DPLO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200225 13:11:25